Latest Traverse Energy (TVETF) Headlines Traverse Energy

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Traverse Energy (TVETF) Headlines

Traverse Energy Ltd. Closes Private Placement Financing
Marketwire - Tue Dec 17, 3:59PM CST
Traverse Energy Ltd. (the "Corporation") (TSX VENTURE: TVL) announces that it has closed the second and final tranche (the "Final Tranche") of its previously announced non-brokered private placement (the "Private Placement") of common shares of the Corporation ("Shares") issued on a "flow through" basis within the meaning of the Income Tax Act (Canada) (the "Tax Act") at $0.84 per Share. The Corporation issued 1,608,750 Shares for gross proceeds of $1,351,350 in the Final Tranche. These Shares are subject to a hold period under applicable securities law until April 18, 2014.

Traverse Energy Ltd. Closes First Tranche of Private Placement Financing
Marketwire - Mon Dec 09, 3:48PM CST
Traverse Energy Ltd. (the "Corporation") (TSX VENTURE: TVL) is pleased to announce that it has successfully closed a first tranche of its previously announced non-brokered private placement (the "Private Placement") of common shares of the Corporation ("Shares") issued on a "flow through" basis eligible for the renunciation of Canadian development expenses within the meaning of the Income Tax Act (Canada). The Corporation issued 2,391,250 Shares for gross proceeds of $2,008,650.

Traverse Energy Ltd. Announces Increase in Size of Private Placement Financing
Marketwire - Thu Dec 05, 11:41AM CST
Traverse Energy Ltd. (the "Corporation") (TSX VENTURE: TVL) reports that due to the oversubscription of its previously announced non-brokered private placement, the Corporation is increasing the size of its private placement of common shares of the Corporation ("Shares") to be issued on a "flow through" basis eligible for the renunciation of Canadian development expenses within the meaning of the Income Tax Act (Canada) at $0.84 per Share (the "Private Placement"). The Corporation will now issue up to 4,000,000 Shares for total gross proceeds of up to $3,360,000. In addition, the Corporation will pay a finder's fee on a portion of the Private Placement consisting of a cash payment equal to 6% of the gross proceeds raised from certain subscriptions.

Traverse Energy Ltd. Announces Private Placement Financing
Marketwire - Tue Nov 19, 4:05PM CST
Traverse Energy Ltd. (the "Corporation") (TSX VENTURE: TVL) intends to complete a non-brokered private placement (the "Private Placement") of up to 2,400,000 common shares of the Corporation ("Shares") to be issued on a "flow through" basis eligible for the renunciation of Canadian development expenses within the meaning of the Income Tax Act (Canada) at $0.84 per Share for total gross proceeds of $2,016,000.

Traverse Energy Announces 2013 Third Quarter Results
Marketwire - Tue Nov 12, 3:42PM CST
Traverse Energy Ltd. ("Traverse" or "the Company") (TSX VENTURE: TVL) presents financial and operating results for the nine months ended September 30, 2013.

Traverse Energy Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013
M2 - Mon Sep 16, 3:30AM CDT
Summary

Traverse Energy Announces 2013 Second Quarter Results
Marketwire - Tue Aug 13, 3:29PM CDT
Traverse Energy Ltd. ("Traverse" or "the Company") (TSX VENTURE: TVL) presents financial and operating results for the six months ended June 30, 2013.

DLB, EDGW, CALD, TVL, PJC, CHCI Are Seasonally Ripe To Go Down In the Next Five Weeks
M2 - Tue Jul 02, 6:01AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of DOLBY LABORATORIES, INC. (NYSELB), Edgewater Technology Inc (NASDAQ:EDGW), Callidus Software Inc (NASDAQ:CALD), Traverse Energy Ltd (NYSE:TVL), Piper Jaffray Companies (NYSEJC), Comstock Holding Companies Inc (NASDAQ:CHCI) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

Market Maker Surveillance Report. UAMY, GCI, PXLW, GTN, TVL, VPCO, Winning Stocks With Lowest Price Friction For Thursday, June 13th 2013
M2 - Fri Jun 14, 2:29AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 3906 companies with "abnormal" market making, 3465 companies with positive Friction Factors and 1715 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Thursday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. United States Antimony Corp (OTCBB:UAMY), Gannett Co Inc (NYSE:GCI), Pixelworks Inc (NASDAQXLW), Gray Television Inc (NYSE:GTN), Traverse Energy Ltd (NYSE:TVL), Vapor Corp (OTC:VPCO). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stoc

Traverse Energy Ltd (TVETF) Stock Research Links

TVETF Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 75

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 176

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 324

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 90

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 345

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 249

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 199

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 209

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading

Top 5 Most Recently Viewed Articles

Earnings Forecast and Expectations for Anika Therapeutics

Updated Category News Views 118

Understanding Anika Therapeutics's Upcoming Earnings Anika Therapeutics (NASDAQ: ANIK) is scheduled to unveil its quarterly earnings report soon. This anticipation is palpable amongst investors who are eager to discover the latest financial insights that the company has to offer. As the date approaches, many are analyzing the potential earnings and what they might mean...

Continue Reading
QYOU Media's Strategic Shift Towards a Creator-Focused Future

Updated Category News Views 202

QYOU Media Completes Sale of Q TV Broadcast Channel QYOU Media Inc., a leading player in the global creator economy, has successfully completed the sale of its free-to-air broadcast channel known as Q TV. This strategic move, executed through its subsidiary QYOU Media India Pvt. Ltd., marks a significant shift towards embracing new growth avenues focused on social media...

Continue Reading
Understanding Recent Disclosures from Octopus Investments

Updated Category News Views 106

Key Disclosure Information by Octopus Investments PUBLIC DISCLOSURE OF INVESTMENT INTERESTS In line with market regulations, Octopus Investments Ltd reveals crucial data regarding interests in relevant securities, particularly concerning Marlowe plc. This disclosure adheres to Rule 8.3 of the Takeover Code, aimed at maintaining transparency in the investment community....

Continue Reading
LiTime's Innovative Battery Solutions Shine in European RV Market

Updated Category News Views 297

LiTime Introduces H190 Series Batteries for RV Enthusiasts At a recent trade show, LiTime made quite the impression with its first participation in Europe’s premier RV exhibition, the Il Salone del Camper. The event, which boasts a large turnout, allowed the company to spotlight its innovative H190 series of batteries tailored for motorhomes. Targeted Designs for Unique...

Continue Reading
Oncolytics Biotech Appoints Jared Kelly as New CEO to Lead Growth

Updated Category News Views 263

Oncolytics Biotech Welcomes New Leadership for Future Growth Oncolytics Biotech Inc. (NASDAQ: ONCY), a notable player in the clinical-stage biotechnology sector focused on immunotherapy for cancer treatment, has proudly appointed Jared Kelly as its new Chief Executive Officer and as a member of its Board of Directors. This significant transition marks a pivotal moment for...

Continue Reading